help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on March 15, 2007, doi:10.1164/rccm.200601-134OC
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200601-134OCv1
176/1/70    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in AJRCCM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moriyama, H.
Right arrow Articles by Gejyo, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moriyama, H.
Right arrow Articles by Gejyo, F.
American Journal of Respiratory and Critical Care Medicine Vol 176. pp. 70-77, (2007)
© 2007 American Thoracic Society
doi: 10.1164/rccm.200601-134OC


Original Article

Two-dimensional Analysis of Elements and Mononuclear Cells in Hard Metal Lung Disease

Hiroshi Moriyama1, Masayoshi Kobayashi2, Toshinori Takada1, Takashi Shimizu1, Masaki Terada1, Jun-Ichi Narita1, Michio Maruyama3, Kouichi Watanabe2,4, Eiichi Suzuki5 and Fumitake Gejyo1

1 Division of Respiratory Medicine, Graduate School of Medical and Dental Sciences, Niigata University; 2 Electron Probe Microanalysis Laboratory, Center of Instrumental Analysis, Niigata University; 3 Department of Internal Medicine, JA Niigata Kouseiren Uonuma Hospital; 4 Division of Dental Biomaterial Science, Graduate School of Medical and Dental Sciences, Niigata University; and 5 Department of General Medicine, Niigata University Medical and Dental Hospital, Niigata, Japan

Correspondence and requests for reprints should be addressed to Toshinori Takada, M.D., Ph.D., Division of Respiratory Medicine, Graduate School of Medical and Dental Sciences, Niigata University, 1-757 Asahimachi-dori, Niigata 951-8510, Japan. E-mail: ttakada{at}med.niigata-u.ac.jp


    ABSTRACT
 TOP
 ABSTRACT
 AT A GLANCE COMMENTARY
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Rationale: Hard metal lung disease is caused by exposure to hard metal, a synthetic compound that combines tungsten carbide with cobalt as well as a number of other metals. Interstitial lung disease caused by hard metal is uniquely characterized by giant cell interstitial pneumonia. The pathogenesis of hard metal lung disease is unclear.

Objectives: To elucidate the distribution of inhaled hard metal and reactive inflammatory cells in biopsy lung tissue from patients with hard metal lung disease.

Methods: Seventeen patients with interstitial lung disease in which tungsten was detected and five control subjects were studied. Detection and mapping of elements were performed with an electron probe microanalyzer equipped with a wavelength dispersive spectrometer. We immunohistochemically stained mononuclear cells, in tissue samples available from five patients, with anti-human CD4, CD8, CD20, CD68, and CD163 antibodies, and compared the distribution of positive cells with hard metal elements.

Measurements and Main Results: Thirteen of 17 patients were pathologically diagnosed as having giant cell interstitial pneumonia. Tungsten and cobalt were accumulated in the centrilobular fibrotic lesions, but were never found in the control lungs. CD8+ lymphocytes and CD163+ monocyte-macrophages were distributed predominantly in centrilobular fibrotic lesions around the hard metal elements. CD163+ colocalized with tungsten. Small numbers of CD8+ and CD163+ cells were also immunohistochemically shown in peribronchiolar areas and alveolar walls.

Conclusions: Macrophages may phagocytose inhaled tungsten via CD163 and play an important role in forming the fibrotic lesion of hard metal lung disease with cytotoxic T lymphocytes.

Key Words: electron probe microanalysis • hard metal • interstitial lung disease • CD163 antigen • CD8-positive T lymphocytes



    AT A GLANCE COMMENTARY
 TOP
 ABSTRACT
 AT A GLANCE COMMENTARY
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Scientific Knowledge on the Subject
Hard metal disease is produced by exposure to hard metal, a compound combining tungsten carbide, cobalt, and other metals. The pathogenesis of hard metal lung disease is unclear.

What This Study Adds to the Field
Macrophages may phagocytose inhaled tungsten via CD163 and play an important role in forming the fibrotic lesion of hard metal lung disease with cytotoxic T lymphocytes.

 
Hard metal is a synthetic compound that combines tungsten carbide with cobalt as well as a number of other metals. It has a hardness nearly that of diamond, which makes it useful in the cutting and grinding of metal tools, stones, and concrete. Occupational hard metal exposure is known to cause hard metal lung disease (HMLD) (13). The pathologic findings of HMLD are predominantly those of interstitial pneumonia and fibrosis (4). In many cases, multinucleated giant cells are prominent, resulting in a pattern of giant cell interstitial pneumonia (GIP) (46). GIP was originally classified by Liebow as one of the idiopathic interstitial pneumonias (7), but it is now recognized as an uncommon form of interstitial lung disease (ILD) that is caused by exposure to hard metal (8). The characteristic distribution of fibrosis in GIP suggests that the inflammation in the centrilobular area initiated by hard metal accumulation plays an important role in the pathogenesis of HMLD. However, the pathogenesis of the disease is still unclear.

Electron probe microanalyzers (EPMAs) irradiate specimens with a finely focused electron beam to obtain information about the elemental composition. Energy-dispersive spectrometers have been applied to the analysis of particles and mapping of chemical elements in lung tissue of HMLD (6, 8, 9). EPMA with a wavelength-dispersive spectrometer (WDS) has a higher sensitivity (10) and this makes it more suitable for detecting elements, which is especially relevant in the case of biosoluble cobalt. We have developed an improved technique for element analysis of tissue sections of 3 µm thickness by means of EPMA with WDS (11). To elucidate the pathogenesis of HMLD, we applied this technique to biopsy lung tissue from patients with HMLD to analyze the distribution of elements in GIP. We also immunophenotyped mononuclear cells infiltrating into the inflammatory lung by immunohistochemistry.


    METHODS
 TOP
 ABSTRACT
 AT A GLANCE COMMENTARY
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Subjects
Lung biopsy specimens from 85 patients with ILD suspected to be of environmental or occupational origin were analyzed by EPMA between 1993 and 2005. Thirty patients had undergone a surgical biopsy and the other specimens were obtained by transbronchial biopsy. Tungsten (W) was detected in surgical biopsies from 17 patients and in transbronchial biopsy from 3 other patients. These 20 patients were considered to have HMLD, but only the 17 patients with a surgical biopsy were included in this study. EPMA analysis was also performed in lung tissue obtained by lobectomy (for the treatment of non–small-cell lung cancer) from five other patients enrolled as control subjects. The study protocol was approved by the Committee of Ethics of Niigata University (Niigata, Japan).

Sample Preparation and Pathologic Study
Each tissue sample was serially cut into 3-µm-thick sections and subjected to pathologic study, EPMA analysis, and immunohistochemistry. For pathologic study, formalin-fixed 3-µm serial sections were stained with hematoxylin–eosin.

Electron Probe Microanalyzer
Examination of tissue sections with an EPMA was performed according to procedures previously described (11). X-ray data were obtained with an EPMA (EPMA 8705; Shimadzu Ltd, Kyoto, Japan). For qualitative element analysis, three areas of 5 x 5 µm to 10 x 10 µm in the centrilobular legion of GIP were screened. For element mapping, we used three wavelength-dispersive crystals: rubidium acid phthalate (RAP), pentaerythritol (PET), and lithium fluoride (LiF). Screened elements, X-ray lines, and crystals were as follows: Al, K, RAP; Si, K, PET; Ti, K, LiF; Cr, K, LiF; Fe, K, LiF; Co, K, LiF; Ta, M, PET; W, M, PET; and Zn, L, RAP. X-ray signals generated from each pixel that was the smallest part of a distribution map were discriminated by wavelength-dispersive crystals and the characteristic X-rays were digitally recorded for the pixel. Pixel size ranged from 1 µm to a 14-µm step for each axis according to the magnifications needed. The pixel count of each axis was always 256 steps. Accordingly, the axis size of the element map was from 256 to 3,584 µm. Scan time for one pixel ranged from 0.3 to 0.8 second. When we needed higher sensitivity for an extremely faint element, we used a longer scan time. Thus, the total time of one area scan calculated from the time of pixel, 0.3 to 0.8 second, multiplied by total pixel number, 256 x 256, was from 19,661 to 52,429 seconds, that is, 5.5 to 14.6 hours. Usually, one map scan provided three element maps in this time. The accelerating voltage and beam current were 20 kV and 0.6 µA, respectively. The distribution of amino nitrogen corresponding to the pathologic image was also mapped for each sample. All of the sampling procedures by EPMA with WDS were computer-operated.

Light Microscopy, Immunohistochemistry, and Statistical Analysis
Immunohistochemical staining was performed for five consecutive specimens according to availability as described previously (12, 13). The number of CD-positive cells in 10 fields (area, 250 x 250 µm) was averaged for alveolar space, alveolar wall, peribronchiole, centrilobular fibrotic lesion, and lymphoid follicle. Statistical comparisons were performed by Mann-Whitney U test.


    RESULTS
 TOP
 ABSTRACT
 AT A GLANCE COMMENTARY
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Characteristics of Subjects
Among the 85 patients with ILD in whom EPMA was performed, no other patient had a record of occupational exposure to hard metal, except for the 20 subjects in whom tungsten was detected in a surgical lung biopsy (17 subjects) or in a transbronchial biopsy (3 subjects, not examined further). Biopsies from two other patients exhibited features of GIP, but no tungsten or cobalt was detected in their lung tissue, and neither had a history of work in the hard metal industry (one subject was a music teacher, and the other had worked for 30 years in a tire factory).

Age, sex, smoking history, exposure period, pathologic diagnosis, and elements detected among the 17 patients with HMLD are summarized in Table 1. All subjects with a known duration of exposure had been exposed until the time of lung biopsy, except for patient 7. Thirteen subjects had typical GIP, as illustrated in Figure 1A. Four patients were considered to have an atypical GIP pattern because the features of GIP, that is, centrilobular fibrosis and giant cell accumulation, were mixed to various extents with interstitial inflammation and fibrosis similar to usual interstitial pneumonia (UIP) (Figures 1D, 1E, and 1F).


Figure 1
View larger version (123K):
[in this window]
[in a new window]

 
Figure 1. Light microscopy findings of hard metal lung disease (HMLD). Surgical lung biopsy specimens obtained from patients with HMLD were pathologically classified as presenting the pattern of giant cell interstitial pneumonia (GIP) (A, patient 5) and atypical GIP (D, patient 17). The GIP pattern is characterized by centrilobular fibrosis (B) and giant cell accumulation within the alveolar space (C). An atypical GIP pattern shows patchy, dense fibrosis and fibroblastic foci (E) distributed mainly in the subpleural and paraseptal zone with multinucleated giant cells (F). Original magnification: (A and D) x5; (B) x20; (C, E, and F) x400.

 

View this table:
[in this window]
[in a new window]

 
TABLE 1. CHARACTERISTICS, PATHOLOGIC DIAGNOSIS, AND ELEMENTS DETECTED IN PATIENTS WITH HARD METAL LUNG DISEASE

 
Two-dimensional Analysis of Biopsy Lung Tissue for Elements, Using an Electron Probe Microanalyzer
The centrilobular fibrotic lesion of GIP observed by hematoxylin–eosin staining was two-dimensionally analyzed by EPMA with WDS to detect Al, Si, Ti, Cr, Fe, Co, Ta, W, and Zn (Figure 2A). Using this technique, we were able to determine the distribution of an element of interest in a tissue sample in a semiquantitative manner (Figure 2B) and to superimpose the element map on a pathologic tissue image by coloring the amino nitrogen green (Figure 2C). The results showed that tungsten was distributed in a relatively high concentration almost throughout the peribronchiolar fibrosis in the centrilobular lesion. By qualitative analysis of a selected area (10 x 10 µm area, indicated by the arrowhead in Figure 2D) in a fibrosing lesion of GIP (Figure 2D), we found Al, Si, Ti, Cr, Fe, and Ta in addition to tungsten (W) (Figure 2E). A list of the elements detected in the 17 patients is shown in Table 1. Interestingly, another major component element of hard metal, cobalt, was detected in only 4 of the 17 patients. It seems that the presence of detectable cobalt was not associated with the exposure period or time since the end of exposure. We also mapped elements in control lung specimens from five patients with non-small cell lung cancer (Figure 3). In addition to Si, we found Al, Ti, Fe, and Zn, but never Co or W, in the bronchioles, vessels, and alveoli (data not shown).


Figure 2
View larger version (101K):
[in this window]
[in a new window]

 
Figure 2. Representative electron probe microanalyzer (EPMA) images of a lung specimen from patient 8 with HMLD presenting a GIP pattern. (A) Centrilobular fibrosing lesion stained with hematoxylin–eosin. (B) Two-dimensional EPMA image of element mapping, indicating the tungsten distribution. Tungsten in the specimen is relatively quantified by color scale, shown on the right, and ranges from blue (minimal) to red (maximal). (C) Qualitative colored image of tungsten distribution is superimposed on the lung tissue image with amino nitrogen colored green. Because the distribution of amino nitrogen corresponds to the pathologic image, detected elements are easily localized in the lung specimen. (D) A gray-scale image of the same fibrosing lesion in GIP is shown. A square, 10 x 10 µm, indicated by the yellow arrowhead, was one-dimensionally analyzed, with results shown in (E). (E) One-dimensional analysis yields peaks of elements on the curves as detected with WDS crystals: rubidium acid phthalate (RAP, green), pentaerythritol (PET, blue), and lithium fluoride (LiF, red). Original magnification: (A) x40. Pixel size is 6 x 6 µm and scan time is 0.75 s/pixel (B). Scale bar: (C) 100 µm.

 

Figure 3
View larger version (112K):
[in this window]
[in a new window]

 
Figure 3. Normal-appearing lung from lobectomy specimens of a patient with non-small cell lung cancer was also two-dimensionally analyzed by EPMA for silicon mapping. Hematoxylin–eosin staining of bronchiole and vessels (A) and alveolus (C) is shown. In comparing the hematoxylin–eosin and EPMA images, silicon appears to be located on the airway surface of the bronchiole (B) and alveolar walls (D), indicated by arrowheads. Original magnification: (A) x60; (C) x100. Scale bars: 100 µm. Pixel size is 6 x 6 µm (B) and 5 x 5 µm (D) and scan time is 0.3 s/pixel (B and D).

 
Comparison of Hematoxylin–Eosin Staining and EPMA Images
We then studied the distribution of elements of interest in GIP fibrosing lesions by comparing hematoxylin–eosin staining and EPMA images. As shown in Figure 4, many elements were accumulated in the peribronchiolar fibrosing tissue. However, the distribution of elements varied widely. Aluminum and silicon were found in that region and were also detected in the surrounding alveolar areas. The results suggest that most of the silicon may be present in the lung tissue as aluminum silicates, with some as silica particles. Areas containing titanium were limited, with most appearing to be distributed at the same position as areas containing tungsten. Cobalt was not detected two-dimensionally at the same magnification as the other elements because it was present in very low amounts (data not shown).


Figure 4
View larger version (99K):
[in this window]
[in a new window]

 
Figure 4. Comparison of a pathologic image stained with hematoxylin–eosin with EPMA mapping of giant cell interstitial pneumonia (GIP) sample from patient 5 with hard metal lung disease. A centrilobular fibrosing lesion of GIP (A) was two-dimensionally analyzed for aluminum (B), silicon (C), titanium (D), and tungsten (E) by EPMA. All the elements detected in the specimen were qualitatively colored and superimposed to a lung tissue image of amino nitrogen (colored green). Note that aluminum and silicon are distributed in the airspace and on the alveolar walls. Original magnification: (A) x30. Scale bar (B): 200 µm [also applies to (CE)]. Pixel size is 14 x 14 µm and scan time is 0.36 s/pixel (BE).

 
Distribution of Inflammatory Cells in Hard Metal Lung Disease
We immunophenotyped lymphocytes and monocyte-macrophages infiltrating lung tissue of HMLD by immunohistochemistry to identify predominant cells in various lesions (Figure 5). The mean numbers of positive cells in 10 fields for each type of structure are summarized in Table 2. The main findings of the immunohistochemical study were as follows: (1) For lymphocytes, CD8+ cells, compared with CD4+ cells, were found predominantly in alveolar walls, peribronchioles, and centrilobular fibrotic lesions as indicated by CD4/8 comparisons; (2) CD20+ cells were found predominantly in lymphoid follicles; and (3) CD163+ monocyte-macrophages were present in alveolar walls, peribronchioles, and centrilobular fibrotic lesions, in addition to their presence in alveolar airspaces as alveolar macrophages. Some of the CD163+ cells were colocalized with particulate black materials and were surrounded by a number of CD8+ lymphocytes.


Figure 5
View larger version (146K):
[in this window]
[in a new window]

 
Figure 5. Representative photographs of immunohistochemistry of various lesions in lung specimens from patients with HMLD with GIP pattern. Mononuclear cells in the airspace and alveolar walls are stained with anti-CD4 (A), anti-CD8 (B), and anti-CD163 antibody (C). Peribronchiolar areas are stained with anti-CD8 (D) and anti-CD163 antibody (E) and lymph follicle is stained with anti-CD20 antibody (F). Mononuclear cells expressing each molecule are stained brown (green arrowheads). Original magnification: (AF) x400.

 

View this table:
[in this window]
[in a new window]

 
TABLE 2. IMMUNOPHENOTYPES OF MONONUCLEAR CELLS IN BIOPSY LUNG TISSUE FROM PATIENTS WITH HARD METAL LUNG DISEASE

 
Comparison of Distribution of Inflammatory Cells and Tungsten
Images of immunohistochemical staining and element distribution by EPMA are compared in Figure 6. Most of the CD163+ cells and CD8+ lymphocytes were distributed in fibrotic lesions surrounding tungsten. Some CD163+ monocyte-macrophages colocalized with tungsten. CD8+ and CD163+ cells were also found in the lung interstitium, such as alveolar walls and peribronchioles. However, tungsten and cobalt were not found in those areas (data not shown).


Figure 6
View larger version (141K):
[in this window]
[in a new window]

 
Figure 6. Comparison of immunohistochemistry and EPMA images of serial sections of lung specimens. A GIP centrilobular fibrosing lesion from patient 5 with hard metal lung disease is stained with monoclonal anti-CD8 (A) and CD163 antibody (B). Mononuclear cells expressing each molecule are stained brown. The same fibrosing lesion was analyzed by EPMA for cobalt (C) and tungsten (D). Note that the distribution of cobalt is limited and all the pixels for cobalt absolutely correspond to the pixels for tungsten. Original magnification: (A and B) x300. Scale bar: (C) 20 µm [also applies to (D)]. Pixel size is 2 x 2 µm and scan time is 0.8 s/pixel (C and D).

 
EPMA and Immunohistochemical Analysis of Giant Cells
Last, we investigated the relationship between tungsten and giant cells in GIP. EPMA revealed that tungsten was located mainly in giant cells, not in regular alveolar macrophages (Figure 7B). On the other hand, they had less CD163 than alveolar macrophages (Figure 7C).


Figure 7
View larger version (72K):
[in this window]
[in a new window]

 
Figure 7. EPMA and immunohistochemical analyses of giant cells present in a lung specimen from patient 8 with hard metal lung disease. Giant cells seen by hematoxylin–eosin staining (A) were scanned for tungsten by EPMA (B). The EPMA image indicates that tungsten is distributed mainly in giant cells. (C) Immunohistochemistry with anti-CD163 antibody shows that giant cells (arrows) express less CD163 than do alveolar macrophages (arrowheads). Original magnification: (A and C) x600. (B) Scale bar, 20 µm; pixel size, 1 x 1 µm; scan time, 0.75 s/pixel.

 

    DISCUSSION
 TOP
 ABSTRACT
 AT A GLANCE COMMENTARY
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Exposure to hard metal dust is well recognized as a cause of the ILD known as HMLD and remains an important occupational health concern. We applied an EPMA with WDS technique to lung specimens of GIP from HMLD and successfully showed the distribution of component elements, that is, hard metal tungsten and cobalt, in the centrilobular fibrotic lesion of GIP. We also studied the immunophenotypes of mononuclear cells infiltrating into the lung tissue.

EPMA with energy-dispersive spectrometry has been used to analyze elements in HMLD tissue (8, 9, 14, 15). Abraham and coworkers discovered that most patients with a diagnosis of GIP had worked in the hard metal industry, and that 30 of 31 patients with GIP were among those 50 patients with the highest concentrations of tungsten as determined by EPMA with energy-dispersive spectrometry (8). For EPMA with WDS, although the sensitivity to element is almost 10 times better than with an energy-dispersive spectrometer (10), the intense beam required to detect elements probably destroys the tissue sample because of the high temperature. We achieved a high specimen current without sample damage, using a thin section on a pure carbon plate (11). In our case, a specimen current of 0.6 µA was used, which is about 10 times higher than is usual in materials science analysis. Furthermore, the scanning speed was slow, 0.3 to 0.8 s at each pixel. The simultaneous use of both a high specimen current and a slow scanning speed made it possible to detect elements in small volumes, such as respirable particles. We used a pixel size ranging from a 1- to 14-µm step for each axis in this study. Analysis by 1-µm step enabled us to resolve individual particles visible by light microscopy and to estimate the composition of each particle. On the other hand, although analysis using a 14-µm step yields only qualitative data for each pixel, we can obtain a mapping of about 3.6 x 3.6 mm area per scan.

Qualitative analysis detected Al, Si, Ti, Cr, Fe, Co, and Ta, besides W, in the patients. Al, Si, Ti, and Fe were also found in control subjects. The main components of hard metal are tungsten carbide (about 90%) and cobalt metal (about 10%), and small amounts of nickel, chromium, and tantalum may be added (16). Therefore, the Al, Si, Ti, and Fe were from environmental dust, whereas other elements, Cr and Ta, should be derived from hard metal. The critical role of cobalt in causing HMLD has been proposed since the 1950s as a result of studies on experimental animals (1719). Verougstraete and coworkers reported that cobalt exposure contributed to a decline in FEV1 over time (20). However, we could find cobalt in only 4 of the 17 patients in the study. Cobalt was proved to be highly soluble in protein fluids (17) and its location on the surface of the hard metal particles also promotes its rapid dissolution. It was not always found in the lung tissue with a histologic diagnosis of GIP, whereas a pathologic diagnosis of GIP is almost pathognomonic for HMLD and tungsten was found in most patients with GIP (8). Several in vitro and animal experiments suggest that tungsten carbide also plays an important part in the pathogenesis of HMLD as a result of a synergistic effect (2123). Thus, the presence of tungsten and cobalt in lung tissues from persons with ILD is pathognomonic for HMLD, but the absence of cobalt may not be a negative finding for HMLD diagnosis. GIP was found in Belgian diamond polishers exposed not to hard metal dust, but to cobalt-containing dust (24). Nevertheless, this condition should be called cobalt-associated GIP rather than HMLD.

It has been suggested that HMLD may develop in some workers through a hypersensitivity reaction (1, 5). Hypersensitivity pneumonitis (HP) is caused by inhaled allergens that elicit lymphocytic inflammation in the peripheral airways and surrounding interstitium. We found tungsten and cobalt in centrilobular fibrosing lesions, suggesting that inhaled hard metal was trapped at the bronchioles and triggered the inflammation of HMLD. The acute phase of HP is characterized by proliferation of CD8+ cytotoxic T lymphocytes (25). A typical feature of inflammatory cells in bronchoalveolar lavage fluid from a patient with HMLD is that the T lymphocyte counts may be normal or increased and the CD4+ cell:CD8+ cell ratio is inverted (2628). Our immunohistochemical findings also indicated that CD8+ cells were to be found predominantly in the centrilobular fibrosing lesions, suggesting that HMLD may result from a hypersensitivity reaction. In addition to the typical HP, a clinically subacute or chronic type of HP has also been reported (2931). Chronic-type HP results from continued low-level exposure to pathogenic antigens. All the patients in this study had an exposure period of at least 2.5 years and more than two-thirds of them were exposed to hard metal for longer than 5 years. Therefore, HMLD may be better classified as chronic HP caused by continued exposure to hard metal.

Although tungsten and cobalt were found only in centrilobular fibrosing lesions, CD8+ lymphocytes and CD163+ monocyte-macrophages were found not only in fibrosing lesions around tungsten but also in other areas of the interstitium, such as alveolar walls and peribronchioles. CD8+ lymphocytes play an essential role in the development of pulmonary injury via the Fas–Fas ligand pathway (32). In addition to this pathway, CD8+ cells can also activate alveolar target cells and trigger their expression of inflammatory mediators monocyte chemoattractant protein-1 and macrophage inflammatory protein-2, leading to monocyte-macrophage–mediated interstitial inflammation (33). Pulmonary interstitial injury of HMLD may also develop and progress via either or both of these mechanisms. CD163 belongs to the scavenger receptor cysteine-rich domain family. It is a monocyte-macrophage differentiation antigen and tissue macrophages have a substantially higher expression compared with monocytes (34). CD163 was first characterized as a scavenger receptor for hemoglobin, mediating endocytosis of hemoglobin:haptoglobin complexes (35), but Philippidis and coworkers have reported that it may act as a molecular switch to promote inflammatory resolution and wound healing (36). Thus, CD163+ cells may on the one hand develop monocyte-macrophage–mediated interstitial inflammation, but on the other hand inhibit the progression of interstitial inflammation by CD8+ lymphocytes via their antiinflammatory activity. CD163 was expressed less on giant cells containing tungsten compared with alveolar macrophages. Low expression of CD163 was also reported on multinucleated giant cells from granulomatous diseases (37). That may be because CD163 molecules on the cell surface had just been diluted by fusion with mononuclear cells, and/or it may indicate that the macrophages carrying tungsten lost their scavenger activity when they fused into giant cells.

The pathologic findings of HMLD are either desquamative interstitial pneumonia or GIP with or without bronchiolitis obliterans, and varying degrees of interstitial fibrosis (46). Most of the patients in this study showed GIP, but we also found a histology of dense fibrosis and fibroblastic foci similar to the UIP pattern. UIP is the histopathologic pattern that identifies patients with idiopathic pulmonary fibrosis (IPF). Epidemiologic studies have indicated that metal dust is one of the risk factors for IPF (38, 39). We are planning to analyze tissue samples of IPF to determine whether elements of hard metal are present, or if not, what kind of elements are predominantly distributed in the UIP tissue from patients with IPF.

In conclusion, this study demonstrated the distribution of elements in biopsy lung tissues from patients with HMLD, using a technique of EPMA with WDS. Tungsten was detected mainly in centrilobular fibrosis and peribronchioles and was closely located with a number of CD163+ macrophages surrounded by CD8+ but not CD4+ lymphocytes. These results suggest that CD163+ macrophages may phagocytose inhaled tungsten and play an important role in forming the fibrotic lesion of HMLD with cytotoxic T lymphocytes.


    Acknowledgments
 
The authors thank the following doctors for the supply of samples: Chiba University Hospital, Dr. Fuminobu Kuroda; Juntendou University Hospital, Dr. Fumiyuki Takahashi and Dr. Shinsaku Jyuuai; Showa University Northern Yokohama Hospital, Dr. Hiroaki Nakajima; Kurobe City Hospital, Dr. Hiroshi Tsuji; Kagoshima University Faculty of Medicine, Dr. Yoshifusa Koreeda; Jikei University Hospital, Dr. Kaoru Aoki; Showa General Hospital, Dr. Masako Kato; University of Fukui Faculty of Medicine, Dr. Masanori Nakanishi; Tohoku University Graduate School of Medicine, Dr. Shinya Okouchi; Nishi-Niigata Chuo National Hospital, Dr. Yasuharu Saito; University of Tsukuba Graduate School of Medicine, Dr. Yukio Ishii; Saitama Cardiovascular and Respiratory Center, Dr. Yoshinori Kawabata; and Kanazawa Graduate University School of Medicine, Dr. Yuko Waseda. The authors offer special thanks to Naofumi Imai for technical assistance and to Dr. Yasuharu Saito for useful discussion.


    FOOTNOTES
 
Supported by a Grant-in-Aid for Scientific Research (16590740).

Originally Published in Press as DOI: 10.1164/rccm.200601-134OC on March 15, 2007

Conflict of Interest Statement: None of the authors has a financial relationship with a commercial entity that has an interest in the subject of this manuscript.

Received in original form January 31, 2006; accepted in final form March 28, 2007


    REFERENCES
 TOP
 ABSTRACT
 AT A GLANCE COMMENTARY
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Nemery B, Verbeken EK, Demedts M. Giant cell interstitial pneumonia (hard metal lung disease, cobalt lung). Semin Respir Crit Care Med 2001;22:435–448.[CrossRef][Medline]
  2. Kelleher P, Pacheco K, Newman LS. Inorganic dust pneumonias: the metal-related parenchymal disorders. Environ Health Perspect 2000;108:685–696.[Medline]
  3. Yokota T, Hasegawa T, Murakami S, Kurashige K, Maruyama M, Satoh M, Suzuki E, Arakawa M. [Hard metal lung with diffuse small nodular shadows]. Nihon Kyobu Shikkan Gakkai Zasshi 1996;34:465–470.[Medline]
  4. Davison AG, Haslam PL, Corrin B, Coutts II, Dewar A, Riding WD, Studdy PR, Newman-Taylor AJ. Interstitial lung disease and asthma in hard-metal workers: bronchoalveolar lavage, ultrastructural, and analytical findings and results of bronchial provocation tests. Thorax 1983;38:119–128.[Abstract]
  5. Cugell DW. The hard metal diseases. Clin Chest Med 1992;13:269–279.[Medline]
  6. Anttila S, Sutinen S, Paananen M, Kreus KE, Sivonen SJ, Grekula A, Alapieti T. Hard metal lung disease: a clinical, histological, ultrastructural and X-ray microanalytical study. Eur J Respir Dis 1986;69:83–94.[Medline]
  7. Liebow AA. Definition and classification of interstitial pneumonias in human pathology. Prog Respir Res 1975;8:1–33.
  8. Abraham JL, Burnett BR, Hunt A. Development and use of a pneumoconiosis database of human pulmonary inorganic particulate burden in over 400 lungs. Scanning Microsc 1991;5:95–104 [discussion 105–108].[Medline]
  9. Abraham JL, Burnett BR. Quantitative analysis of inorganic particulate burden in situ in tissue sections. Scan Electron Microsc 1983;(Pt 2):681–696.
  10. Goldstein JI, Newbury DE, Echlin P, Joy DC, Romig JAD, Lyman CE, Fiori C, Lifshin E. Scanning electron microscopy and X-ray microanalysis. New York: Plenum Press; 1994. pp. 499–501.
  11. Watanabe K, Miyakawa O, Kobayashi M. New method for quantitative mapping of metallic elements in tissue sections by electron probe microanalyser with wavelength dispersive spectrometers. J Electron Microsc (Tokyo) 2001;50:77–82.[Abstract/Free Full Text]
  12. Higashi K, Naito M, Takeya M, Ando M, Araki S, Takahashi K. Ontogenetic development, differentiation, and phenotypic expression of macrophages in fetal rat lungs. J Leukoc Biol 1992;51:444–454.[Abstract]
  13. Moriyama H, Yamamoto T, Takatsuka H, Umezu H, Tokunaga K, Nagano T, Arakawa M, Naito M. Expression of macrophage colony-stimulating factor and its receptor in hepatic granulomas of Kupffer-cell-depleted mice. Am J Pathol 1997;150:2047–2060.[Abstract]
  14. Auchincloss JH, Abraham JL, Gilbert R, Lax M, Henneberger PK, Heitzman ER, Peppi DJ. Health hazard of poorly regulated exposure during manufacture of cemented tungsten carbides and cobalt. Br J Ind Med 1992;49:832–836.[Medline]
  15. Schwarz Y, Kivity S, Fischbein A, Abraham JL, Fireman E, Moshe S, Dannon Y, Topilsky M, Greif J. Evaluation of workers exposed to dust containing hard metals and aluminum oxide. Am J Ind Med 1998;34:177–182.[CrossRef][Medline]
  16. Lison D. Human toxicity of cobalt-containing dust and experimental studies on the mechanism of interstitial lung disease (hard metal disease). Crit Rev Toxicol 1996;26:585–616.[Medline]
  17. Harding HE. Notes on the toxicology of cobalt metal. Br J Ind Med 1950;7:76–78.[Medline]
  18. Delahant AB. An experimental study of the effects of rare metals on animal lungs. AMA Arch Ind Health 1955;12:116–120.[Medline]
  19. Schepers GW. The biological action of particulate cobalt metal; studies on experimental pulmonary histopathology. AMA Arch Ind Health 1955;12:127–133.[Medline]
  20. Verougstraete V, Mallants A, Buchet JP, Swennen B, Lison D. Lung function changes in workers exposed to cobalt compounds: a 13-year follow-up. Am J Respir Crit Care Med 2004;170:162–166.[Abstract/Free Full Text]
  21. Lison D, Lauwerys R, Demedts M, Nemery B. Experimental research into the pathogenesis of cobalt/hard metal lung disease. Eur Respir J 1996;9:1024–1028.[Abstract]
  22. Anard D, Kirsch-Volders M, Elhajouji A, Belpaeme K, Lison D. In vitro genotoxic effects of hard metal particles assessed by alkaline single cell gel and elution assays. Carcinogenesis 1997;18:177–184.[Abstract/Free Full Text]
  23. Van Goethem F, Lison D, Kirsch-Volders M. Comparative evaluation of the in vitro micronucleus test and the alkaline single cell gel electrophoresis assay for the detection of DNA damaging agents: genotoxic effects of cobalt powder, tungsten carbide and cobalt–tungsten carbide. Mutat Res 1997;392:31–43.[Medline]
  24. Demedts M, Gheysens B, Nagels J, Verbeken E, Lauweryns J, van den Eeckhout A, Lahaye D, Gyselen A. Cobalt lung in diamond polishers. Am Rev Respir Dis 1984;130:130–135.[Medline]
  25. Patel AM, Ryu JH, Reed CE. Hypersensitivity pneumonitis: current concepts and future questions. J Allergy Clin Immunol 2001;108:661–670.[CrossRef][Medline]
  26. Forni A. Bronchoalveolar lavage in the diagnosis of hard metal disease. Sci Total Environ 1994;150:69–76.[CrossRef][Medline]
  27. Michetti G, Mosconi G, Zanelli R, Migliori M, Gaffuri G, Villa R, Michetti L. Bronchoalveolar lavage and its role in diagnosing cobalt lung disease. Sci Total Environ 1994;150:173–178.[CrossRef][Medline]
  28. Migliori M, Mosconi G, Michetti G, Belotti L, D'Adda F, Leghissa P, Musitelli O, Cassina G, Motta T, Seghizzi P, et al. Hard metal disease: eight workers with interstitial lung fibrosis due to cobalt exposure. Sci Total Environ 1994;150:187–196.[CrossRef][Medline]
  29. Fink JN, Sosman AJ, Barboriak JJ, Schlueter DP, Holmes RA. Pigeon breeders' disease: a clinical study of a hypersensitivity pneumonitis. Ann Intern Med 1968;68:1205–1219.[Medline]
  30. Haitjema T, van Velzen-Blad H, van den Bosch JM. Extrinsic allergic alveolitis caused by goose feathers in a duvet. Thorax 1992;47:990–991.[Abstract]
  31. Kim KT, Dalton JW, Klaustermeyer WB. Subacute hypersensitivity pneumonitis to feathers presenting with weight loss and dyspnea. Ann Allergy 1993;71:19–23.[Medline]
  32. Kuwano K, Hagimoto N, Kawasaki M, Yatomi T, Nakamura N, Nagata S, Suda T, Kunitake R, Maeyama T, Miyazaki H, et al. Essential roles of the Fas–Fas ligand pathway in the development of pulmonary fibrosis. J Clin Invest 1999;104:13–19.[Medline]
  33. Zhao MQ, Stoler MH, Liu AN, Wei B, Soguero C, Hahn YS, Enelow RI. Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8+ T cell recognition. J Clin Invest 2000;106:R49–R58.[Medline]
  34. Sanchez C, Domenech N, Vazquez J, Alonso F, Ezquerra A, Dominguez J. The porcine 2A10 antigen is homologous to human CD163 and related to macrophage differentiation. J Immunol 1999;162:5230–5237.[Abstract/Free Full Text]
  35. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK. Identification of the haemoglobin scavenger receptor. Nature 2001;409:198–201.[CrossRef][Medline]
  36. Philippidis P, Mason JC, Evans BJ, Nadra I, Taylor KM, Haskard DO, Landis RC. Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ Res 2004;94:119–126.[Abstract/Free Full Text]
  37. Komohara Y, Hirahara J, Horikawa T, Kawamura K, Kiyota E, Sakashita N, Araki N, Takeya M. AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype. J Histochem Cytochem 2006;54:763–771.[Abstract/Free Full Text]
  38. Baumgartner KB, Samet JM, Coultas DB, Stidley CA, Hunt WC, Colby TV, Waldron JA. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Am J Epidemiol 2000;152:307–315.[Abstract/Free Full Text]
  39. Hubbard R, Cooper M, Antoniak M, Venn A, Khan S, Johnston I, Lewis S, Britton J. Risk of cryptogenic fibrosing alveolitis in metal workers. Lancet 2000;355:466–467.[Medline]

Related articles in AJRCCM:

Hard Metal Lung Disease: Still Hard to Understand
Benoit Nemery and Jerrold L. Abraham
AJRCCM 2007 176: 2-3. [Full Text]  



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
T. S. Nawrot, E. Alfaro-Moreno, and B. Nemery
Update in Occupational and Environmental Respiratory Disease 2007
Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 696 - 700.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. D. Blanc
Is Giant Cell Interstitial Pneumonitis Synonymous with Hard Metal Lung Disease?
Am. J. Respir. Crit. Care Med., October 15, 2007; 176(8): 834 - 834.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. Takada, H. Moriyama, and F. Gejyo
Is Giant Cell Interstitial Pneumonitis Synonymous with Hard Metal Lung Disease?
Am. J. Respir. Crit. Care Med., October 15, 2007; 176(8): 834 - 835.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200601-134OCv1
176/1/70    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in AJRCCM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moriyama, H.
Right arrow Articles by Gejyo, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moriyama, H.
Right arrow Articles by Gejyo, F.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2007 American Thoracic Society